Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339248 · ClinicalTrials.gov registry record
Markers for Breast Cancer
A clinical trial of Breast Cancer, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,632
- Enrollment target
- 1
- Study location
NCT00339248 is a study of Breast Cancer that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,632 participants, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00339248, a study of Breast Cancer, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,632 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will analyze blood samples to identify substances that are associated with the development of breast cancer. It will determine if: * Women who are diagnosed with a benign breast condition that is related to a considerably increased risk of breast cancer are more likely to have certain gene variants than women diagnosed with conditions related to very little increased breast cancer risk * Women with benign breast conditions who subsequently develop breast cancer are more likely to have certain gene variants than women with similar benign conditions who do not develop breast cancer. This study will examine blood samples from premenopausal women who underwent breast biopsy (removal of a small piece of breast tissue for microscopic examination) at four hospitals in Grand Rapids, MI, from 1977 to 1987 and were found to have benign breast disease. The women, who agreed to participate in a study of markers for breast cancer, also provided a blood sample and were interviewed for information on their breast cancer risk factors, family history of breast cancer, use of medications, and history of medical conditions. This study will retrieve the biopsy reports for these women, determine which of them later developed breast cancer, and perform genotyping on their blood samples. The information from this study may help in future diagnosis and treatment of breast cancer.
Conditions Studied
Study Locations (1)
Maryland
- NCI Frederick Cancer Research Center - Frederick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,632 participants |
| Start Date | 2004-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00339248
The ClinicalTrials.gov registry entry for NCT00339248 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,632 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00339248 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00339248 about?
NCT00339248 is a clinical study titled "Markers for Breast Cancer". This study will analyze blood samples to identify substances that are associated with the development of breast cancer. It will determine if: * Women who are diagnosed with a benign breast condition that is related to a considerably increased risk of breast cancer are more likely to have certain ge...
What is the current status of trial NCT00339248?
This trial is currently completed. The enrollment target is 2,632 participants. The study started on 2004-12.
What conditions does trial NCT00339248 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT00339248?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00339248 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.